What type of study is this?

This is a Observational study (also classified as: In Vitro Study, Animal Study).

August 25, 2025Open Access

RIPK3 Promotes Acute Pancreatitis via TRAF6-K63 Ubiquitination and Downstream Signaling Activation

View Full Paper

Ask AI

Bookmark

Authors

Research reveals RIPK3's dual role in macrophages, promoting inflammation and implicating TRAF6 in acute pancreatitis progression.

RIPK3 significantly promotes the inflammatory response in cases of acute pancreatitis, not just necroptosis.
Inhibition of RIPK3 with GSK-872 demonstrated reduced pancreatic damage in experimental models.
This study employed a conditional knockout model to clarify the specific role of macrophage RIPK3.
These findings suggest potential therapeutic strategies focusing on RIPK3 to treat acute pancreatitis.

Chen et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark